Advertisement

Binding Sites of Monoclonal Anti-Carbohydrate Antibodies

  • J. Thurin
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 139)

Abstract

This chapter presents an overview of monoclonal antibodies (mAbs) directed to carbohydrates in mammalian systems with well-characterized specificities, together with some of the information obtained from their use. Because of the rapidly increasing number of this kind of reagent not all available mAbs are included. Naturally occurring mAbs and embryological markers and their suspected immunogenicity have been extensively reviewed by Hakomori (1984) and Feizi (1985).

Keywords

Blood Group Blood Group Antigen Human Blood Group Glycolipid Antigen Lewis Blood Group Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abe K, McKibbin JM, Hakomori S-i (1983) The monoclonal antibody directed to diffucosylated type 2 chain. Fucα 1 → 2 Galβ 1 → 4GlcNAc (3 ← 1 αFuc)—; Y determinant. J Biol Chem 258:11793–11797.PubMedGoogle Scholar
  2. Abe K, Levery SB, Hakomori S-i (1984) The antibody specific for type 1 chain blood group A determinant. J Immunol 132:1951–1954.PubMedGoogle Scholar
  3. Abe K, Hakomori S-i, Oshiba S (1986) Differential expression of difucosyl type 2 chain (LeY) defined by monoclonal antibody AH6 in different locations of colonie epithelia, various histological types of colonic polyps, and adenocarcinomas. Cancer Res 46:2639–2644.PubMedGoogle Scholar
  4. Atkinson B, Ernst C, Herlyn M, Steplewski Z, Sears H, Koprowski H (1982) Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res 42:4820–4822.PubMedGoogle Scholar
  5. Baker DA, Sugii S, Kabat KA, Ratcliffe RM, Hermentin P, Lemieux RU (1983) Immunochemical studies of the combining sites of Forssman hapten specific hemagglutinins from Dolichos biflorus and Helix pomatia. Biochemistry 22:2741–2750.PubMedCrossRefGoogle Scholar
  6. Blaineau C, LePendu J, Arnaud D, Connan F, Avner P (1983) The glycosidic antigen recognized by a novel monoclonal antibody, 75.12, is developmentally regulated on mouse embryonal carcinoma cells. EMBO J 2:2217–2222.PubMedGoogle Scholar
  7. Blaszczyk M, Hansson OC, Karlsson KA, Larson G, Strömberg N, Thurin J, Herlyn M, Steplewski Z, Koprowski H (1984 a) Lewis blood group antigens defined by monoclonal anti-colon carcinoma antibodies. Arch Biochem Biophys 233:161–168.PubMedCrossRefGoogle Scholar
  8. Blaszczyk M, Ross AH, Ernst CS, Marchisio M, Atkinson B, Pak KY, Steplewski Z, Koprowski H (1984b) A fetal glycolipid expressed on adenocarcinomas of the colon. Int J Cancer 33:313–318.PubMedCrossRefGoogle Scholar
  9. Blaszczyk M, Pak KY, Herlyn M, Sears HF, Steplewski Z (1985) Characterization of Lewis antigens in normal colon and gastrointestinal adenocarcinomas. Proc Natl Acad Sci USA 82:3552–3556.PubMedCrossRefGoogle Scholar
  10. Breimer ME (1984) Tissue specificity of glycosphingolipids as expressed in pancreas and small intestine of blood group A and B human individuals. Arch Biochem Biophys 228:71–85.PubMedCrossRefGoogle Scholar
  11. Breimer ME, Hansson GC, Karlsson K-A, Leffler H (1982) Glycosphingolipids of rat tissues. J Biol Chem 257:557–568.PubMedGoogle Scholar
  12. Bremer EG, Levery SB, Sonnino S, Ghidoni R, Canevari S, Kannagi R, Hakomori S-i (1984) Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr 1 expressed in normal and neoplastic epithelial cells of human mammary gland. J Biol Chem 259:14773–14777.PubMedGoogle Scholar
  13. Brockhaus M, Magnani JM, Blaszczyk M, Steplewski Z, Koprowski H, Karlsson KA, Larson G, Ginsburg V (1981) Monoclonal antibodies directed against the human Leb blood group antigen. J Biol Chem 256:13223–13225.PubMedGoogle Scholar
  14. Brockhaus M, Magnani JM, Herlyn M, Blaszczyk M, Steplewski Z, Koprowski H, Ginsburg Y (1982) Monoclonal antibodies directed against the sugar sequence of lacto-N-fucopentaose III are obtained from mice immunized with human tumors. Arch Biochem Biophys 217:647–651.PubMedCrossRefGoogle Scholar
  15. Brockhaus M, Wysocka M, Magnani JL, Steplewski Z, Koprowski H, Ginsburg V (1985) Normal salivary mucin contains the gastrointestinal cancer-associated antigen detected by monoclonal antibody 19-9 in the serum mucin of patients. Vox Sang 48:34–38.PubMedCrossRefGoogle Scholar
  16. Brodin T, Hellström I, Hellström K-E, Karlsson K-A, Sjögren H-O, Strömberg N, Thurin J (1985) Mouse monoclonal antibodies with specificity for melanoma-associated disialyllactosylceramide (GD3) also react with the structural analogue disialylparagloboside. Biochim Biophys Acta 837:349–353.PubMedCrossRefGoogle Scholar
  17. Brodin T, Thurin J, Strömberg N, Karlsson K-A, Sjögren H-O (1986) Production of oligosaccharidebinding monoclonal antibodies of diverse specificities by immunization with purified tumor-associated glycolipids inserted into liposomes with lipid A. Eur J Immunol (in press).Google Scholar
  18. Brown A, Feizi T, Gooi HC, Embleton MJ, Picard JK, Baldwin RW (1983) A monoclonal antibody against human colonic adenoma recognizes difucosylated type-2-blood-group chains. Biosci Rep 3:163–170.PubMedCrossRefGoogle Scholar
  19. Bundle DR, Gidney MAJ, Kassam N, Rahman AFR (1982) Hybridomas specific for carbohydrates; synthetic human blood group antigens for the production, selection, and characterization of monoclonal typing reagents. J Immunol 129:678–682.PubMedGoogle Scholar
  20. Cahan LD, Irie RF, Singh R, Cassidenti A, Paulson JC (1982) Identification of a human neuroecto-dermal tumor antigen (OFA-1-2) as a ganglioside. Proc Natl Acad Sci USA 79:7629–7633.PubMedCrossRefGoogle Scholar
  21. Chen H-T, Kabat EA (1985) Immunological studies of blood groups. The combining site specificities of mouse monoclonal hybridoma anti-A and anti-B. J Biol Chem 260:13208–13217.PubMedGoogle Scholar
  22. Cheresh DA, Varki AP, Varki NM, Stallcup WB, Levine J, Reisfeld RA (1984 a) A monoclonal antibody recognizes an O-acetylated sialic acid in a human melanoma associated ganglioside. J Biol Chem 259:7453–7459.PubMedGoogle Scholar
  23. Cheresh DA, Harper JR, Schulz G, Reisfeld RA (1984 b) Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells. Proc Natl Acad Sci USA 81:5767–5771.PubMedCrossRefGoogle Scholar
  24. Chou DKH, Ilyas AA, Evans CE, Quarles RH, Jungalwala FB (1985 a) Structure of a glycolipid reacting with monoclonal IgM in neuropathy and with HNK-1. Biochem Biophys Res Commun 128:383–388.PubMedCrossRefGoogle Scholar
  25. Chou DKH, Ilyas AA, Evans CE, Quarles RH, Jungalwala FB (1985b) Sulfated glucuronyl neolactoseries of glycoilipids in peripheral nerves. In: Proceedings of the VIIIth international symposium of glycoconjugates (additional Abstract). Preager, New York, p 49.Google Scholar
  26. Clausen H, Levery SB, McKibbin JM, Hakomori S-i (1985 a) Blood group A determinants with mono-and di-fucosyl type I chain in human erythrocyte membranes. Biochemistry 24:3578–3586.PubMedCrossRefGoogle Scholar
  27. Clausen H, Levery S, Nudelman E, Tsuchia S, Hakomori S-i (1985b) Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: chemical basis of qualitative A1 and A2 distinction. Proc Natl Acad Sci USA 82:1199–1203.PubMedCrossRefGoogle Scholar
  28. Dubois C, Magnani JL, Grunwald GB, Spitalnik SL, Trisler GD, Nirenberg M, Ginsburg Y (1986) Monoclonal antibody 18B8, which detects synapse-associated antigens, binds to ganglioside GT3 (II3(NeuNAc)3LacCer). J Biol Chem 261:3826–3830.PubMedGoogle Scholar
  29. Ernst C, Atkinson B, Wysocka M, Blaszczyk M, Herlyn M, Sears H, Steplewski Z, Koprowski H (1984a) Monoclonal antibody localization of Lewis antigens in fixed tissue. Lab Invest 50:394–400.PubMedGoogle Scholar
  30. Ernst C, Thurin J, Atkinson B, Wurzel H, Herlyn M, Strömberg N, Civin C, Koprowski H (1984b) Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues. Am J Pathol 117:451–461.PubMedGoogle Scholar
  31. Falk K-E, Karlsson K-A, Larson G, Thurin J, Blaszczyk M, Steplewski Z, Koprowski H (1983) Mass spectrometry of a human glycolipid antigen being defined by mouse monoclonal antibody NS-19-9. Biochem Biophys Res Commun 110:383–391.PubMedCrossRefGoogle Scholar
  32. Feizi T (1985) Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature 314:53–57.PubMedCrossRefGoogle Scholar
  33. Fredman P, Richert ND, Magnani JL, Willingham MC, Pastan I, Ginsburg V (1983) A monoclonal antibody that precipitates the glycoprotein receptor for epidermal growth factor is directed against the human blood group H type 1 antigen. J Biol Chem 258:11206–11210.PubMedGoogle Scholar
  34. Fredman P, Jeansson S, Lycke E, Svennerholm L (1985) A monoclonal antibody reacting specificially with ganglioside GD1b in human brain. FEBS Lett 189:23–26.PubMedCrossRefGoogle Scholar
  35. Fredman P, Brezicka T, Holmgren J, Lindholm L, Nilsson O, Svennerholm L (1986) Binding specificity of monoclonal antibodies to ganglioside Fuc-GMI. Biochim Biophys Acta 875:316–323.PubMedCrossRefGoogle Scholar
  36. Fukushi Y, Hakomori S-i, Nudelman E, Cochran N (1984a) Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and tri-fucosylated type 2 chain. J Biol Chem 259:4681–4685.PubMedGoogle Scholar
  37. Fukushi Y, Nudelman E, Levery SB, Rauvala H, Hakomori S-i (1984b) Novel fucolipids accumulation in human cancer. III. A Hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuNAcY3III3Fuc2nLc6). J Biol Chem 259:10511–10517.PubMedGoogle Scholar
  38. Fukushima K, Hirota M, Terasaki PI, Wakisaka A, Togashi H, Chia D, Suyama N, Fukushi Y, Nudelman E, Hakomori S-i (1984) Characterization of sialylated Lewisx as a new tumor associated antigen. Cancer Res 44:5279–5285.PubMedGoogle Scholar
  39. Furukawa K, Mattes MJ, Lloyd KO (1985) A1 and A2 erythrocytes can be distinguished by reagents that do not detect structural differences between the two cell types. J Immunol 135:4090–4094.PubMedGoogle Scholar
  40. Galanos C, Luderitz O, Westphal O (1971) Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. Eur J Biochem 24:116–122.PubMedCrossRefGoogle Scholar
  41. Ginsburg V, Fredman P, Magnani JL (1984) Cancer-associated carbohydrate antigens detected by monoclonal antibodies. Contrib Oncol 19:44–50.Google Scholar
  42. Ginsburg V, Magnani JM, Spitalnik SL, Spitalnik PF, Roberts DO, Dubois C (1985) Carbohydrate antigens detected by monoclonal antibodies. In: Proceedings of the VIII international symposium on glycocojugates. Preager, New York, pp 550–551.Google Scholar
  43. Gooi HC, Feizi T, Kapadia A, Knowles BB, Solter D, Evans HJ (1981) Stage specific embryonic antigen involves α1 → 3 fucosylated type 2 blood group chains. Nature 292:156–158.PubMedCrossRefGoogle Scholar
  44. Gooi HC, Williams LK, Uemura K, Hounsell EF, Mcllinney RAJ, Feizi T (1983) A marker of human endoderm defined by a monoclonal antibody involves type 1 blood groups chains. Mol Immunol 30:607–613.CrossRefGoogle Scholar
  45. Goujet-Zalc C, Guerci A, Dubois G, Zalc B (1986) Schwann cell marker defined by a monoclonal antibody (224–58) with species cross-reactivity II. Molecular characterization of the epitope. J Neurochem 46:435–439.PubMedCrossRefGoogle Scholar
  46. Hakomori S-i (1981) Blood group ABH and Ii antigens of human erythrocytes: chemistry, polymorphism and their developmental change. Semin Hematol 18:39–62.PubMedGoogle Scholar
  47. Hakomori S-i (1984) Monoclonal antibodies directed to cell-surface carbohydrates. In: Monoclonal antibodies and functional cell lines. Plenum, New York, pp 67–100.CrossRefGoogle Scholar
  48. Hakomori S-i (1985) Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res 45:2405–2414.PubMedGoogle Scholar
  49. Hakomori S-i, Jeanloz RW (1964) Isolation of a glycolipid containing fucose, glucose, and glucos-amine from human cancerous tissue. J Biol Chem 239:3606–3607.Google Scholar
  50. Hakomori S-i, Kanagi R (1983) Glycosphingolipids as tumor-associated and differentiation markers. J Natl Cancer Inst 71:231–251.PubMedGoogle Scholar
  51. Hakomori S-i, Patterson CM, Nudelman E, Seikguchi K (1983 b) A monoclonal antibody directed to N-acetylneuraminosyl α 2→6 galactosyl residue in gangliosides and glycoproteins. J Biol Chem 258:11819–11822.PubMedGoogle Scholar
  52. Hanisch F-G, Uhlenbruck G, Dienst C (1984) Structure of tumor-associated carbohydrate antigen CA 19-9 on human seminal-plasma glycoproteins from healthy donors. Eur J Biochem 144:467–474.PubMedCrossRefGoogle Scholar
  53. Hansson GC, Zopf D (1985) Biosynthesis of the cancer-associated sialyl-Lea antigen. J Biol Chem 260:9388–9392.PubMedGoogle Scholar
  54. Hansson GC, Karlsson K-A, Larson G, McKibbin JM, Blaszczyk M, Herlyn M, Steplewski Z, Koprowski H (1983) Mouse monoclonal antibodies against human cancer cell lines with specificities for blood group and related antigens. J Biol Chem 258:4091–497.PubMedGoogle Scholar
  55. Hansson GC, Karlsson K-A, Thurin J (1984) Glycosphingolipid patterns of the epithelial and nonepithelial compartments of rat large intestine. Biochim Biophys Acta 792:281–292.PubMedCrossRefGoogle Scholar
  56. Herlyn M, Koprowski H (1985) New tumor markers in human gastrointestinal cancer. In: Clinical laboratory molecular analyses. Grune and Stratton, New York.Google Scholar
  57. Herlyn M, Blaszczyk M, Benicelli J, Sears HF, Ernst C, Ross AH, Koprowski H (1985) Selection of monoclonal antibodies detecting serodiagnostic human tumor markers. J Immunol Methods 80:107–116.PubMedCrossRefGoogle Scholar
  58. Herlyn M, Ross AH, Balaban G, Herlyn D, Thurin J, Koprowski H (to be published) Cell biology of melanoma and non-malignant lesions. In: Pigment cell: pathobiology of melanoma. Karger, Basel.Google Scholar
  59. Hindsgaul O, Norberg T, LePendu J, Lemieux RU (1982) Synthesis of type 2 human blood group antigenic determinants. The H, X, and Y haptens and variations of the H type 2 determinants as probes for the combining site of the lectin I of Ulex europaeus. Carbohydr Res 109:109–142.PubMedCrossRefGoogle Scholar
  60. Hindsgaul O, Khare DP, Bach M, Lemieux RU (1985) Molecular recognition. III. The binding of the H-type 2 human blood group determinant by the lectin I of Ulex europeus 63:2653–2658.Google Scholar
  61. Hirabayashi Y, Hamaoka A, Matsumoto M, Matsubara T, Tagawa M, Wakabayashi S, Taniguchi M (1985) Syngeneic monoclonal antibody against melanoma antigen with interspecies crossreactivity recognizes GM3, a prominent ganglioside of B 16 melanoma. J Biol Chem 260:13328–13333.PubMedGoogle Scholar
  62. Hirohashi S, Clause H, Yamada T, Shimosato Y, Hakomori S-i (1985) Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and-81 expressed in cancer of blood group 0 or B individuals: its identification as Tn antigen. Proc Natl Acad Sci USA 82:7039–7043.PubMedCrossRefGoogle Scholar
  63. Holmes EH, östränder GK, Hakomori S-i (1986) Biosynthesis of the sialyl-Lex determinant carried by type 2 chain glycosphingolipids (IV3NeuNAcIII3FucnLc4, VI3NeuNAcV3FucnLc6, and VI3N-euNAcIII3V3Fuc2nLc6) in human lung carcinoma PC9 cells. J Biol Chem 261:3737–3743.PubMedGoogle Scholar
  64. Houghton AN, Mintzer D, Cordon-Cardo C, Welt S, Fliegel B, Vadhan S, Carswell E, Melamed MR, Oettgen HF, Old LJ (1985) Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Natl Acad Sci USA 82:1242–1246.PubMedCrossRefGoogle Scholar
  65. Hounsell EF, Gooi HC, Feizi T (1981) The monoclonal antibody anti-SSEA-1 discriminates between fucosylated type 1 and type 2 blood group chains. FEBS Lett 131:279–282.PubMedCrossRefGoogle Scholar
  66. Huang LC, Civin CK, Magnani JL, Shaper JH, Ginsburg V (1983) My-1, the human myeloid specific antigen detected by mouse monoclonal antibodies, is a sugar sequence found in lacto-N-fucopentaose III. Blood 61:1020–1023.PubMedGoogle Scholar
  67. IUPAC-IUB Commission on Biochemical Nomenclature (1977) The nomenclature of lipids. Biochem J 171:21–35.Google Scholar
  68. Ito M, Suzuki E, Naiki M, Sendo F, Arai S (1984) Carbohydrates as antigenic determinants of tumor-associated antigens recognized by monoclonal anti-tumor antibodies produced in a syngeneic system. Int J Cancer 34:689–697.PubMedCrossRefGoogle Scholar
  69. Kannagi R, Cochran N, Ishigami F, Hakomori S-i, Andrews P, Knowles BB, Solter D (1983 a) Stage-specific embryonic antigens (SSEA-3 and-4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 2:2355–2361.PubMedGoogle Scholar
  70. Kanagi R, Levery SB, Ishigami F, Hakomori S-i, Shevinsky LH, Knowles BB, Solter D (1983 b) New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J Biol Chem 258:8934–8942.Google Scholar
  71. Kimmel KA, Carey TE, Judd WJ, McClatchkey KD (1986) Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant 76:9–19.Google Scholar
  72. Koprowski H (1984) The Gordon Wilson lecture: monoclonal antibodies in human cancer. Trans Am Clin Clinat Assoc 96:81–97.Google Scholar
  73. Koprowski H, Steplewski Z, Herlyn D, Herlyn M (1978) Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci USA 75:3405–3409.PubMedCrossRefGoogle Scholar
  74. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Führer P (1979) Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 5:957–972.PubMedCrossRefGoogle Scholar
  75. Kumazaki T, Yoshida A (1984) Biochemical evidence that secretor gene, Se, is a structural gene encoding a specific fucosyltransferase Proc Natl Acad Sci USA 81:4193–4197.Google Scholar
  76. Lemieux RU (1982) The binding of carbohydrate structures with antibodies and lectins. In: IUPAC, frontiers in chemistry. Pergamon, Oxford, pp 3–24.Google Scholar
  77. Lemieux RU, Wong TC, Liao J, Kabat EA (1984) The combining site of anti-I Ma (group 1). Mol Immunol 21:751–759.PubMedCrossRefGoogle Scholar
  78. Lemieux RU (1985) How oligosaccharides are recognized for specific noncovalent binding by antibodies and lectins. In: Proceedings of the VIIIth international symposium on glycoconjugates. Praeger, New York, p 177.Google Scholar
  79. Lemieux RU, Venot AP, Spohr U, Bird P, Mandai G, Morishima N, Hindsgaul O, Bundle DR (1985) Molecular recognition. V. The binding of the B human blood group determinant by hybridoma monoclonal antibodies 63:2664–2668.Google Scholar
  80. LePendu J, Fredman P, Richter N, Magnani JL, Willingham MC, Pastan I, Oriol R, Ginsburg V (1985) Monoclonal antibody 101 that precipitates the glycoprotein receptor for epidermal growth factor is directed against the Y-antigen, not the H type 1 antigen. Carbohydr Res 141:347–349.CrossRefGoogle Scholar
  81. Lindholm L, Holmgren J, Svennerholm L, Fredman P, Nilsson O, Persson B, Myrvold H, Lagergård T (1983) Monoclonal antibodies against gastrointestinal tumor-associated antigens isolated as monosialogangliosides. Int Arch Allergy Appl Immunol 71:178–181.PubMedCrossRefGoogle Scholar
  82. Lloyd KO, Larson G, Strömberg N, Thurin J, Karlsson K-A (1983) Mouse monoclonal antibody F-3 recognizes the difucosyl type-2 blood group structure. Immunogenetics 17:537–541.PubMedCrossRefGoogle Scholar
  83. Magnani JL, Brockhaus M, Smith DF, Ginsburg V, Blaszczyk M, Mitchell KF, Steplewski Z, Koprowski H (1981) A monosialo-ganglioside is a monoclonal antibody-defined antigen in colon carcinoma. Science 212:55–56.PubMedCrossRefGoogle Scholar
  84. Magnani JL, Nilsson B, Brockhaus M, Zopf D, Steplewski Z, Koprowski H, Ginsburg V (1982) A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem 257:14365–14369.PubMedGoogle Scholar
  85. Magnani JL, Steplewski Z, Koprowski H, Ginsburg V (1983) Identification of the gastrointestinal cancer-associated antigen defined by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res 43:5489–5492.PubMedGoogle Scholar
  86. Magnani JL, Ball ED, Fanger MW, Hakomori S-i, Ginsburg V (1984) Monoclonal antibodies PMN 6, PMN 29, and PM-81 bind differently to glycolipids containing a sugar sequence occurring in lacto-N-fucopentaose III. Arch Biochem Biophys 233:501–506.PubMedCrossRefGoogle Scholar
  87. Månsson J-E, Fredman P, Nilsson O, Lindholm L, Holmgren J, Svennerholm L (1985) Chemical structure of carcinoma ganglioside antigens defined by monoclonal antibody CA-50 and some allied gangliosides from human pancreatic adenocarcinoma. Biochim Biophys Acta 834:110–117.PubMedCrossRefGoogle Scholar
  88. Nilsson O, Månsson J-E, Lindhohn L, Holmgren J, Svennerhohn L (1985) Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody. FEBS Lett 182:398–402.PubMedCrossRefGoogle Scholar
  89. Nowinski R, Berglund C, Lane J, Lostrom M, Bernstein I, Young WW, Hakomori S-i, Hill L, Cooney M (1980) Human monoclonal antibody against Forssman antigen. Science 210:537–539.PubMedCrossRefGoogle Scholar
  90. Nudelman E, Hakomori S-i, Knowles BB, Solter D, Nowinski RC, Tarn MR, Young WW (1980) Monoclonal antibody directed to the stage-specific embryonic antigen (SSEA-1) reacts with a branched glycosphingolipid similar in structure to Ii antigen. Biochem Biophys Res Commun 97:443–451.PubMedCrossRefGoogle Scholar
  91. Nudelman E, Hakomori S-i, Kannagi R, Levery S, Yeh M-Y, Hellström K-E, Hellström I (1982) Characterization of a human melanoma-associated antigen defined by a monoclonal antibody, 4.2. J Biol Chem 257:12752–12756.PubMedGoogle Scholar
  92. Nudelman E, Kannagi R, Hakomori S-i, Parsons M, Lipinski M, Wiels J, Fellous M, Tursz T (1983) A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science 220:509–511.PubMedCrossRefGoogle Scholar
  93. Olding L, Thurin J, Svalander C, Koprowski H (1984) Expression of gastrointestinal carcinomaassociated antigen (GICA) detected in human fetal tissues by monoclonal antibody NS-19-9. Int J Cancer 34:187–192.PubMedCrossRefGoogle Scholar
  94. Olding L, Åhren C, Thurin J, Karlsson K-E, Svalander C, Koprowski H (1985) Gastrointestinal carcinoma-associated antigen detected by a monoclonal antibody in dysplasia and adenocacinoma associated with chronic ulcerative colites. Int J Cancer 36:131–136.PubMedCrossRefGoogle Scholar
  95. Portoucalian J, Zwingelstein G, Doré J-F (1979) Lipid composition of human malignant melanoma tumors at various levels of malignant growth. Eur J Biochem 94:19–23.CrossRefGoogle Scholar
  96. Pukel CS, Lloyd KO, Travassos LR, Dippold WG, Oettgen HF, Old LJ (1982) GD3, a prominent ganglioside of human melanoma. J Exp Med 155:1133–1147.PubMedCrossRefGoogle Scholar
  97. Raux H, Labbe F, Fondeneche M-C, Koprowski H (1983) A study of gastrointestinal cancer-associated antigen (GICA) in human fetal organs. Int J Cancer 34:315–319.CrossRefGoogle Scholar
  98. Rodeck U, et al. (to be published).Google Scholar
  99. Saito M, Yu RK, Cheung N-KV (1985) Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell. Biochem Biophys Res Commun 127:1–7.PubMedCrossRefGoogle Scholar
  100. Sakamoto J, Furukawa K, Cordon-Cardo C, Yin BWT, Rettig WJ, Oettgen HF, Old LJ, Lloyd KO (1986) Expression of Lewisa, Lewis b, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor derived cell lines. Cancer Res 46:1553–1561.PubMedGoogle Scholar
  101. Siddiqui B, Buehler J, DeGregorio MW, Macher BA (1984) Differential expression of ganglioside GD3 by human leukocytes and leukemia cells. Cancer Res 44:5262–5265.PubMedGoogle Scholar
  102. Solter D, Knowles BB (1978) Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 75:5565–5569.PubMedCrossRefGoogle Scholar
  103. Spohr U, Hindsgaul O, Lemieux RU (1985 a) Molecular recognition. II. The binding of the Lewis b and Y human blood group determinants by the lectin iV of Griffonia simplicifolia. Can J Chem 63:2644–2652.CrossRefGoogle Scholar
  104. Spohr U, Morishima N, Hindsgaul O, Lemieux RU (1985 b) Molecular recognition. IV. The binding of the Lewis b human blood group determinant by a hybridoma monoclonal antibody. Can J Chem 63:2659–2663.CrossRefGoogle Scholar
  105. Steplewski Z, Spira G, Blaszczyk M, Lübeck MD, Radbruch A, Illges H, Herlyn D, Rajewski K, Scharff M (1985) Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants. Proc Natl Acad Sci USA 82:8653–8657.PubMedCrossRefGoogle Scholar
  106. Symington FW, Bernstein ID, Hakomori S-i (1984 a) Monoclonal antibody specific for lactosylceramide. J Biol Chem 259:6008–6012.PubMedGoogle Scholar
  107. Symington FW, Fenderson BA, Hakomori S-i (1984 b) Fine specificity of a monoclonal antitesticular cell antibody for glycolipids with terminal N-acetyl-D-glucosamine structure. Mol Immunol 21:877–882.PubMedCrossRefGoogle Scholar
  108. Szulman AE (1960) The histological distribution of blood group substances A and B in man. J Exp Med 111:785–799.PubMedCrossRefGoogle Scholar
  109. Szulman AE (1964) The histological distribution of blood group substances in man as disclosed by immunofluorescence. J Exp Med 119:503–516.PubMedCrossRefGoogle Scholar
  110. Tai T, Paulson JC, Cahan LD, Irie RF (1983) Ganglioside GM2 as a human tumor antigen (OFA-I-1). Proc Natl Acad Sci USA 80:5392–5396.PubMedCrossRefGoogle Scholar
  111. Tai T, Cahan LD, Tsuchida T, Saxton RE, Irie R, Morton DL (1985) Immunogenicity of melanoma-associated gangliosides in cancer patients. Int J Cancer 35:607–612.PubMedCrossRefGoogle Scholar
  112. Thurin J, Herlyn M, Hindsgaul O, Strömberg N, Karlsson K-A, Elder D, Steplewski Z, Koprowski H (1985) Proton NMR and fast-atom bombardment mass spectrometry analysis of the melanoma-associated ganglioside 9-O-acetyl-GD3. J Biol Chem 260:14556–14563.PubMedGoogle Scholar
  113. Thurin J, Thurin M, Herlyn M, Elder DE, Clark WH, Steplewski Z, Koprowski H (to be published) GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progression.Google Scholar
  114. Thurin M, Thurin J, Hindsgaul O, Karlsson K-A, Steplewski Z, Koprowski H (to be published) Y and blood group H type 2 glycolipid antigens accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody: Isolation and characterization by mass spectrometry and NMR spectroscopy.Google Scholar
  115. Thurin J, Thurin M, Kimoto Y, Lübeck M, Herlyn M, Elder DE, Smereszynska M, Karlsson K-A, Clark WH, Steplewski Z, Koprowski H (to be published) Antimelanoma antibody, directed against both antigens GD2 and GD3, indicates the significance of multiple specificity towards tumor-associated antigens in anti-tumor activity.Google Scholar
  116. Uemura K-i, Macher BA, DeGregorio M, Scudder P, Beuhler J, Knapp W, Feizi T (1985) Glycosph-ingolipid carriers of carbohydrate antigens of human myeloid cells recognized by monoclonal antibodies. Biochim Biophys Acta 846:26–36.PubMedCrossRefGoogle Scholar
  117. Uhlenbruck G, van Meensel-Maene U, Hanish F-G, Dienst C (1984) Unexpected occurrence of the CA 19-9 tumor marker in normal human seminal plasma. Hoppe-Seylers Z Physiol Chem 365:613–617.PubMedCrossRefGoogle Scholar
  118. Urdal DL, Brentnall TA, Bernstein ID, Hakomori S-i (1983) A granulocyte reactive monoclonal antibody, IG10, identifies the Galβ1 →4GlcNAc(3 ← 1αFuc)-(X determinant) expressed in HL-60 cells on both glycolipid and glycoprotein molecules. Blood 62:1022–1026.PubMedGoogle Scholar
  119. Watanabe T, Pukel CS, Takeyama H, Lloyd KO, Shiku H, Li LTC, Travassos LR, Oettgen HF, Old LJ (1982) Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. J Exp Med 156:1884–1889.PubMedCrossRefGoogle Scholar
  120. Watkins WM (1980) Biochemistry and genetics of the ABO, Lewis and P blood group systems. Adv Hum Genet 10:1–136.PubMedGoogle Scholar
  121. Willison KR, Karol RA, Suzuki A, Kundu SK, Marcus DM (1982) Neutral glycolipid antigens as developmental markers of mouse teratocarcinoma and early embryos: and immunologic and chemical analysis. J Immunol 129:603–609.PubMedGoogle Scholar
  122. Yamamoto M, Boyer AM, Schwarting GA (1985) Fucose-containing glycolipids are stage-and region-specific antigens in developing embryonic brain of rodents. Proc Natl Acad Sci USA 82:3045–3049.PubMedCrossRefGoogle Scholar
  123. Yeh M-Y, Hellström I, Abe K, Hakomori S-i, Hellström K-E (1982) A cell-surface antigen which is present in the ganglioside fraction and shared by human melanomas. Int J Cancer 29:269–275.PubMedCrossRefGoogle Scholar
  124. Young WW, Hakomori S-i (1981a) Therapy of mouse lymphoma with monoclonal antibodies to glycolipid: selection of low antigenic variants in vivo. Science 211:487–489.PubMedCrossRefGoogle Scholar
  125. Young WW, Johnson HS, Tamura Y, Karlsson K-A, Larson G, Paker JMR, Khare DP, Spohr U, Baker DA, Hindsgaul O, Lemieux RU (1983) Characterization of monoclonal antibodies specific for the Lewis-a human blood group determinant. J Biol Chem 258:4890–4894.PubMedGoogle Scholar
  126. Young WW, MacDonald EMS, Nowinski RC, Hakomori S-I (1979) Production of monoclonal antibodies specific for two distinct steric portions of the glycolipids ganglio-N-tertaosylceramide (asialo-GM2). J Exp Med 150:1008–1019.PubMedCrossRefGoogle Scholar
  127. Young WW, Portoukalian J, Hakomori S-i (1981b) Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto-N-glycosyl type II chain. J Biol Chem 256:10967–10972.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1988

Authors and Affiliations

  • J. Thurin
    • 1
  1. 1.Wistar Institute of Anatomy and BiologyPhiladelphiaUSA

Personalised recommendations